ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $345,336 | -27.4% | 51,697 | -8.8% | 0.00% | 0.0% |
| Q2 2023 | $475,814 | +411.6% | 56,712 | +170.6% | 0.00% | – |
| Q1 2022 | $93,000 | -11.4% | 20,956 | -20.0% | 0.00% | – |
| Q4 2021 | $105,000 | -54.3% | 26,203 | 0.0% | 0.00% | – |
| Q3 2021 | $230,000 | -69.7% | 26,203 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $759,000 | +772.4% | 66,960 | +90.6% | 0.00% | – |
| Q1 2020 | $87,000 | -56.9% | 35,132 | +1.2% | 0.00% | – |
| Q4 2019 | $202,000 | +10.4% | 34,724 | 0.0% | 0.00% | – |
| Q3 2019 | $183,000 | -12.0% | 34,724 | 0.0% | 0.00% | – |
| Q2 2019 | $208,000 | -30.4% | 34,724 | +5.0% | 0.00% | -100.0% |
| Q1 2019 | $299,000 | +9.1% | 33,068 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $274,000 | -18.5% | 33,068 | +35.7% | 0.00% | 0.0% |
| Q3 2018 | $336,000 | +73.2% | 24,369 | 0.0% | 0.00% | – |
| Q2 2018 | $194,000 | – | 24,369 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,009,131 | $7,568,000 | 1.15% |
| Knoll Capital Management, LLC | 124,096 | $931,000 | 0.96% |
| 683 Capital Management, LLC | 1,000,000 | $7,500,000 | 0.66% |
| Perceptive Advisors | 3,085,458 | $23,141,000 | 0.65% |
| MANGROVE PARTNERS IM, LLC | 324,019 | $2,430,000 | 0.16% |
| Stanley-Laman Group, Ltd. | 64,029 | $480,000 | 0.11% |
| WOODSTOCK CORP | 67,759 | $508,000 | 0.10% |
| Hikari Power Ltd | 107,858 | $809,000 | 0.10% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $336,000 | 0.05% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 750,000 | $5,625,000 | 0.01% |